FUJIFILM Toyama Chemical s Clinical Stage Antifungal Program - Ownership and Business Overview

Life ScienceCompany

FUJIFILM Toyama Chemical s Clinical Stage Antifungal Program Ownership

Who owns FUJIFILM Toyama Chemical s Clinical Stage Antifungal Program?

FUJIFILM Toyama Chemical s Clinical Stage Antifungal Program is owned by Appili Therapeutics. It was acquired on November 21, 2019.

FUJIFILM Toyama Chemical s Clinical Stage Antifungal Program Business Overview

Where is FUJIFILM Toyama Chemical s Clinical Stage Antifungal Program headquartered?

FUJIFILM Toyama Chemical s Clinical Stage Antifungal Program is headquartered in Tokyo, Japan.

What sector is FUJIFILM Toyama Chemical s Clinical Stage Antifungal Program in?

FUJIFILM Toyama Chemical s Clinical Stage Antifungal Program is a life science company.

Life Science M&A Summary in 2019

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2019. The largest life science acquisition in 2019 was Celgene - which was acquired by Bristol-Myers Squibb for $74.0B.

Join Mergr to view all 251 acquisitions of life science companies in 2019, including 44 acquisitions by private equity firms, and 207 by strategics.

FUJIFILM Toyama Chemical Co., Ltd.'s Clinical Stage Antifungal Program (ATI-2307)

Tokyo,
Japan,

FUJIFILM Toyama Chemical Co., Ltd.'s Clinical Stage Antifungal Program (T-2307) is a developer of novel antifungal drugs.


 Subscribe to unlock this and 208,602
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for FUJIFILM Toyama Chemical s Clinical Stage Antifungal Program

Life Science Companies , Japan Companies